Market Overview

UPDATE: ISI Group Initiates CVS Caremark at Overweight, $53.50 PT

Related CVS
Retail ETFs Hitting Highs Ahead Of Holidays
The Top 25 Analysts On Wall Street
Making Money With Charles Payne: 11/24/14 (Fox Business)
Related CVS
Retail ETFs Hitting Highs Ahead Of Holidays
The Top 25 Analysts On Wall Street
Making Money With Charles Payne: 11/24/14 (Fox Business)

ISI Group initiated its coverage on CVS Caremark (NYSE: CVS) with a rating of Overweight and a price target of $53.50.

ISI Group commented, "Our thesis for CVS is based on our view of continued share gain at the pharmacy given the success of Maintenance Choice and the continuation of the WAG/ESRX dispute, improved growth and profitability at Caremark as a result of innovative solutions and the streamlining initiative, and a very shareholder friendly approach to capital deployment and enhanced capital returns."

CVS Caremark closed at $46.90 on Wednesday.

Latest Ratings for CVS

DateFirmActionFromTo
Nov 2014Deutsche BankMaintainsHold
Nov 2014FBR CapitalMaintainsOutperform
Sep 2014Cowen & CompanyUpgradesMarket PerformOutperform

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

Posted-In: ISI GroupAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (CVS)

Around the Web, We're Loving...

Get Benzinga's Newsletters